NRGN and early-onset autosomal dominant Alzheimer disease: Research from our group has shown that Ng can be detected at increased concentrations in cerebrospinal fluid (CSF) from Alzheimer's disease (AD) patients, both as full‐length protein (Thorsell et al., 2010) and as C‐terminal fragments (Kvartsberg et al., 2015).